Relevance of Pharmacogenomics and Multidisciplinary Management in a Young-Elderly Patient With KRAS Mutant Colorectal Cancer Treated With First-Line Aflibercept-Containing Chemotherapy

Introduction: Intensive oncological treatment integrated with resection of metastases raised the clinical outcome of metastatic colorectal cancer (MCRC). In clinical practice, complex evaluation of clinical (age, performance status, comorbidities), and biological (tumoral genotype, pharmacogenomic)...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruera, Gemma, D'Andrilli, Antonio, Simmaco, Maurizio, Guadagni, Stefano, Rendina, Erino Angelo, Ricevuto, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417602/
https://www.ncbi.nlm.nih.gov/pubmed/32850329
http://dx.doi.org/10.3389/fonc.2020.01155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417602/
https://www.ncbi.nlm.nih.gov/pubmed/32850329
http://dx.doi.org/10.3389/fonc.2020.01155

Ejemplares similares